TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $305,208 | -19.6% | 19,729 | -18.4% | 0.03% | -18.4% |
| Q2 2023 | $379,790 | -14.6% | 24,175 | -10.5% | 0.04% | -17.4% |
| Q1 2023 | $444,977 | +50.4% | 27,001 | +42.4% | 0.05% | +35.3% |
| Q4 2022 | $295,776 | +19.3% | 18,960 | -0.7% | 0.03% | +3.0% |
| Q3 2022 | $248,000 | -1.2% | 19,103 | +6.8% | 0.03% | -2.9% |
| Q2 2022 | $251,000 | -12.5% | 17,889 | -10.6% | 0.03% | -2.9% |
| Q1 2022 | $287,000 | +22.1% | 20,008 | +16.3% | 0.04% | +25.0% |
| Q4 2021 | $235,000 | +89.5% | 17,205 | +126.9% | 0.03% | +64.7% |
| Q3 2021 | $124,000 | -32.2% | 7,583 | -30.1% | 0.02% | -37.0% |
| Q2 2021 | $183,000 | -4.2% | 10,852 | +3.6% | 0.03% | -12.9% |
| Q1 2021 | $191,000 | +12.4% | 10,476 | +12.1% | 0.03% | -3.1% |
| Q4 2020 | $170,000 | -16.7% | 9,347 | -18.4% | 0.03% | -27.3% |
| Q3 2020 | $204,000 | +52.2% | 11,458 | +53.3% | 0.04% | +46.7% |
| Q2 2020 | $134,000 | -82.8% | 7,476 | -85.4% | 0.03% | -76.9% |
| Q1 2020 | $779,000 | -22.7% | 51,228 | -1.6% | 0.13% | +6.6% |
| Q4 2019 | $1,008,000 | +89.5% | 52,070 | +65.8% | 0.12% | +48.8% |
| Q3 2019 | $532,000 | -2.0% | 31,413 | +0.9% | 0.08% | -4.7% |
| Q2 2019 | $543,000 | +14.1% | 31,135 | +29.3% | 0.09% | +2.4% |
| Q1 2019 | $476,000 | +120.4% | 24,084 | +83.3% | 0.08% | +44.8% |
| Q4 2018 | $216,000 | +483.8% | 13,142 | +531.5% | 0.06% | +427.3% |
| Q3 2018 | $37,000 | -7.5% | 2,081 | -8.8% | 0.01% | -21.4% |
| Q2 2018 | $40,000 | -73.2% | 2,281 | -64.4% | 0.01% | -74.1% |
| Q1 2018 | $149,000 | -15.3% | 6,405 | -0.7% | 0.05% | -22.9% |
| Q4 2017 | $176,000 | +2.3% | 6,447 | -0.2% | 0.07% | -1.4% |
| Q3 2017 | $172,000 | +20.3% | 6,457 | +7.2% | 0.07% | +12.7% |
| Q2 2017 | $143,000 | +21.2% | 6,022 | +16.6% | 0.06% | +21.2% |
| Q1 2017 | $118,000 | +742.9% | 5,164 | +488.2% | 0.05% | +642.9% |
| Q4 2016 | $14,000 | -69.6% | 878 | -59.7% | 0.01% | -76.7% |
| Q3 2016 | $46,000 | +1433.3% | 2,179 | +868.4% | 0.03% | +1400.0% |
| Q2 2016 | $3,000 | -93.5% | 225 | -89.8% | 0.00% | -93.3% |
| Q1 2016 | $46,000 | +119.0% | 2,213 | +142.7% | 0.03% | +100.0% |
| Q4 2015 | $21,000 | +2000.0% | 912 | +1040.0% | 0.02% | +1400.0% |
| Q3 2015 | $1,000 | 0.0% | 80 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $1,000 | – | 80 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |